Dr. Reddy’s Q4 dips 86% on lower sales, multiple one offs to ₹221 crore
On the SSA, the company said it recorded ₹453 crore as a reduction of revenue from sale of goods in its Global Generics Segment. | Photo Credit: The Hindu Pharma major Dr. Reddy’s Laboratories reported consolidated net profit slumped to ₹221.3 crore for the March quarter compared to ₹1,586.7 crore a year earlier on the…
Read More “Dr. Reddy’s Q4 dips 86% on lower sales, multiple one offs to ₹221 crore” »